GROWTH HORMONE FAMILY
CJC-1295 + Ipamorelin (No DAC) 5mg/5mg
Growth hormone research peptide blend.
Bundle & save
Free shipment protection · Overnight shipping available · Ships from our Naples, FL facility
Free shipping
on orders over $150
Damage protection
replacement guarantee
Secure checkout
256-bit SSL
Certificate of Analysis
Third-party tested · ISO/IEC 17025 accredited
99%
purity
✓ Passed full QC panel
- Variant
- CJC-1295 + Ipamorelin (No DAC) 5mg/5mg · 5 mg / 5 mg
- Lot #
- TBD
- Labeled
- 5 mg / 5 mg
- Tested
- —
Full QC panel
- Purity (HPLC)
- 99%
- Net Peptide Content
- Pass
- Identity (HPLC-MS)
- Confirmed
- Heavy Metals (ICP-MS)
- Not detected
- Sterility
- No growth
- Endotoxin (LAL)
- Within limits
Purity, lot and tested date are per-lot; remaining QC rows are representative — exact values on the CoA.
Compound Information
Chemical and structural properties
Chemical identity verified via NIH PubChem · biological targets characterized from the peer-reviewed literature.
Molecular profile
Components
- CJC-1295 (No DAC)
- CAS 863288-34-0C152H252N44O42
- Ipamorelin
- CAS 170851-70-4C38H49N9O5
- Type
- Combination blend
Biological targets
Interactions
- Primary target
- GHRH receptor (CJC-1295) and ghrelin receptor (Ipamorelin)
- Pathway
- Complementary GHRHR and GHS-R1a stimulation of GH release
- Mechanism
- Co-formulated CJC-1295 (no DAC) and Ipamorelin
- Research area
- Growth-hormone axis research
Physical properties
Handling & Storage
- Appearance
- White lyophilized powder
- Solubility
- Soluble in sterile or bacteriostatic water; reconstitute prior to use
- Storage
- 2-8 deg C, protect from light
- Country of origin
- USA
Sources & References
Peer-reviewed research
Indexed in NIH PubMed. Provided for research context; not a claim of clinical outcome.
THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults
2006 · PMID 16352683
Teichman SL et al.
View Source ↗PHYSIOLOGY & BEHAVIOR
The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin-induced weight loss in ferrets: Anamorelin also exhibits anti-emetic effects via a central mechanism
2024 · PMID 39043357
Lu Z et al.
View Source ↗SUBSTANCE USE & MISUSE
Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions
2016 · PMID 26771670
Van Hout MC et al.
View Source ↗EUROPEAN JOURNAL OF ENDOCRINOLOGY
Ipamorelin, the first selective growth hormone secretagogue
1998 · PMID 9849822
Raun K et al.
View Source ↗DRUG TESTING AND ANALYSIS
Advances in the detection of growth hormone releasing hormone synthetic analogs
2021 · PMID 34665524
Memdouh S et al.
View Source ↗
⚠ Important research notice
PRODUCTS ARE INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly prohibited by law. Products should only be handled by licensed, qualified professionals. Products sold are not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food, or cosmetic.
All the research peptides you need, with the peace of mind at your fingertips.
Research updates from Aminologix
Catalog updates, new research compounds, and quality-documentation news. For researchers and labs. No spam, unsubscribe anytime.